Find out all about your favorite commercial!

Advertisers

Advertisers of the VRAYLAR TV Spot, 'Unfinished Projects'

VRAYLAR TV commercial - Unfinished Projects
VRAYLAR

About VRAYLARVRAYLAR is a medication developed by AbbVie, a research-driven biopharmaceutical company based in North Chicago, Illinois. It is a prescription drug used for the treatment of schizophreni...

What the VRAYLAR TV commercial - Unfinished Projects is about.

VRAYLAR TV commercial - Unfinished Projects

Title: VRAYLAR TV Spot - "Unfinished Projects"

: Life is full of unfinished projects. The ones we start with good intentions, but never quite get around to finishing.

: We all know the feeling. The weight of unfulfilled promises, aspirations, and dreams. It can be overwhelming.

: Meet Emily, an artist who has lost her way.

Emily (looking frustrated): I used to be so creative, but now I can't seem to finish anything.

: Introducing VRAYLAR, a revolutionary virtual reality program designed to help you find the motivation to complete those unfinished projects.

: Through VRAYLAR, you'll embark on a journey of self-discovery and creative reawakening.

: With VRAYLAR's innovative technology, you'll dive into immersive environments that inspire and push you to overcome obstacles.

: Whatever your passion may be, VRAYLAR is here to help you unleash your full potential.

: Don't let unfinished projects hold you back any longer. Take the first step towards a more fulfilling life.

: VRAYLAR, helping you conquer the world, one project at a time.

[Screen fades to black]

[End]

Disclaimer: The above script is a fictional portrayal of a VRAYLAR TV Spot. Any resemblance to real products, services, or persons is purely coincidental. VRAYLAR is a fictional product and does not exist in reality. This script is written solely for entertainment and creative purposes.

VRAYLAR TV commercial - Unfinished Projects produced for VRAYLAR was first shown on television on July 18, 2019.

Frequently Asked Questions about vraylar tv spot, 'unfinished projects'

VRAYLAR is a prescription medicine used in adults: along with antidepressant medicines to treat major depressive disorder (MDD) for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder. to treat depressive episodes that happen with bipolar I (dipolar depression)

VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*

For depressive episodes associated with bipolar I disorder, three studies showed Vraylar was significantly superior to placebo at the end of week 6 using the MADRAS total score.

The main neurotransmitters affected by Vraylar are dopamine and serotonin. Dopamine plays a role in causing hallucinations, delusions, and thought disorders.

Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to cause elevations in blood sugar or total cholesterol levels, sedation, or weight gain.

Cariprazine is now FDA-approved as an adjunctive therapy to antidepressants. The US Food and Drug Administration (FDA) has approved AbbVie's cariprazine (Vraylar) as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults.

VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*

VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*

Up to 10% of people taking Vraylar report sleepiness or drowsiness as a side effect; the risk of this side effect increases with higher dosages, and these people may prefer taking it at night.

Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms* Treat mixed episodes (symptoms of depression and mania at the same time)* Reduce the overall severity of the condition.

Cariprazine has an average rating of 5.8 out of 10 from a total of 477 reviews on Drugs.com. 47% of reviewers reported a positive experience, while 36% reported a negative experience.

Vraylar® (cariprazine) is an atypical antipsychotic drug indicated for the treatment of adults with bipolar I disorder, and schizophrenia, as well as an adjunctive treatment for major depressive disorder (MDD) with antidepressants.

Videos

Watch VRAYLAR TV Commercial, 'Unfinished Projects'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Products

Products Advertised

VRAYLAR
TV commercials

Similar commercials

REXULTI TV Spot, 'Still Masking'
REXULTI TV Spot, 'Isolated'
438 January 31, 2023
REXULTI TV Spot, 'Build on Your Progress'
NUPLAZID TV Spot, 'Seeing Things'
1107 November 21, 2018
REXULTI TV Spot, 'On the Outside'
REXULTI TV Spot, 'Masking Depression'
Caesars Entertainment TV Spot, 'Betting 101: Prop Bets' Featuring Kenny Mayne
Bob's Discount Furniture TV Spot, 'What is Bob-O-Pedic?'
CAPLYTA TV Spot, 'Real Progress'
792 August 10, 2020
REXULTI TV Spot, 'Hard Enough'
505 October 3, 2021
Oofos TV Spot, '5x Baseball All-Star, J.D. Martinez, Slides Oofos Into His Routine' Song by Tina Neumann
Oofos TV Spot, 'OOFOS Official mOOver: Yuma Haidara'